According to the Japan Broadcasting Association (NHK), on the 28th, Japan's Kobayashi Pharmaceutical announced that the number of deaths after taking the company's red yeast rice health products has increased to 4, all due to kidney disease after taking the health products. According to a report by Kyodo News on the 27th, the number of people hospitalized after taking problem health products has risen to 106.
Image source: Screenshot of the report by the Japan Broadcasting Association (NHK).
According to previous reports, on March 22, Japan's Kobayashi Pharmaceutical Company said that some consumers have recently developed kidney disease after using the company's health products containing red yeast rice ingredients. On the 24th, Kobayashi Pharmaceutical said that it had supplied red yeast rice to about 50 beverage and food manufacturers.
The president of Kobayashi Pharmaceutical Co., Ltd. apologized
Fumio Kishida spoke out
On March 28, local time, Akihiro Kobayashi, president of Japan's Kobayashi Pharmaceutical Co., Ltd., apologized at a private shareholders' meeting held in Osaka on the same day, saying that consumers who took products such as red yeast cholesterol granules sold by the company had kidney diseases, etc., and apologized for this.
On the same day, Japanese Prime Minister Fumio Kishida said that efforts must be made to find out the cause and consider taking all necessary countermeasures in response to the damage to consumers' health products containing red yeast rice ingredients from Kobayashi Pharmaceutical Company.
Kobayashi Pharmaceutical will compensate Japanese consumers with 120 yuan vouchers
Focusing on the damage to people's health caused by the products of Kobayashi Pharmaceutical Company, a well-known Japanese pharmaceutical company, Kobayashi Pharmaceutical has released a message on its official website on the 27th that it will compensate relevant consumers.
A staff member of the public relations department of Kobayashi Pharmaceutical Co., Ltd. said: "For Japan, compensation will be made according to the type and quantity of goods, and a voucher of 2,500 yen (about 120 yuan) will be compensated for one product. The issue of compensation for Chinese mainland is still under discussion, and we are unable to answer some specific circumstances at present. ”
Kobayashi Pharmaceutical (China) statement
On the evening of March 27, Kobayashi Pharmaceutical (China) Co., Ltd. issued a statement to assist Kobayashi Pharmaceutical Co., Ltd. in voluntarily recalling products related to the use of red koji raw materials, saying that none of the three products involved in this self-recall were marketed in the Chinese mainland market, and some Chinese consumers purchased related products through overseas cross-border platforms, overseas physical stores or other channels, in this regard, Kobayashi Pharmaceutical will provide assistance in product recall.
Source: Kobayashi Pharmaceutical China official account
The three products involved in the announcement on the official website of Kobayashi Pharmaceutical Co., Ltd. are red yeast cholesterol granules, nattokinase granules, and cholesterol-lowering health support granules, all of which contain red yeast rice ingredients and can lower cholesterol as the main selling point, and these three products can be purchased at ordinary drugstores in Japan. On a number of e-commerce platforms in China, there are also official stores of Kobayashi Pharmaceutical that sell its products.
At present, the official stores of various e-commerce platforms have said that they have removed red koji cholesterol granules from the shelves, and the customer service said that consumers who have purchased them in the store can apply for a refund and return.
Source: China News Network, Kobayashi Pharmaceutical China, CCTV News, China-Singapore Jingwei, CCTV Finance, The Paper, etc
Editor: Yang Rui
Editor: Zhou Xiaoxue Final review: Zhou Jianjun
If you think it's good, order one
and
Forward it up!